Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| regulatory T cell | 8 studies | 22% ± 4% | |
| CD4-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
| GABAergic neuron | 4 studies | 27% ± 7% | |
| T follicular helper cell | 3 studies | 29% ± 7% | |
| glutamatergic neuron | 3 studies | 28% ± 6% | |
| interneuron | 3 studies | 28% ± 15% |
Insufficient scRNA-seq data for expression of FBLN7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1087.63 | 653 / 653 | 93% | 7.96 | 562 / 605 |
| breast | 99% | 810.11 | 456 / 459 | 86% | 6.32 | 956 / 1118 |
| prostate | 93% | 315.69 | 229 / 245 | 86% | 3.92 | 432 / 502 |
| liver | 89% | 222.34 | 201 / 226 | 81% | 5.78 | 327 / 406 |
| adrenal gland | 95% | 286.89 | 245 / 258 | 66% | 4.29 | 151 / 230 |
| skin | 96% | 488.86 | 1745 / 1809 | 57% | 5.21 | 271 / 472 |
| uterus | 99% | 570.89 | 169 / 170 | 51% | 3.59 | 232 / 459 |
| lung | 92% | 256.14 | 531 / 578 | 45% | 2.39 | 517 / 1155 |
| brain | 70% | 361.31 | 1849 / 2642 | 46% | 4.04 | 325 / 705 |
| spleen | 100% | 356.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.01 | 1 / 1 |
| blood vessel | 100% | 887.94 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 604.48 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 71% | 242.19 | 15 / 21 | 27% | 1.82 | 136 / 504 |
| kidney | 35% | 78.22 | 31 / 89 | 63% | 5.25 | 564 / 901 |
| pancreas | 25% | 37.07 | 83 / 328 | 56% | 2.37 | 100 / 178 |
| esophagus | 60% | 124.09 | 862 / 1445 | 21% | 0.84 | 39 / 183 |
| intestine | 65% | 146.36 | 624 / 966 | 8% | 0.35 | 40 / 527 |
| ovary | 36% | 100.51 | 65 / 180 | 27% | 1.35 | 116 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 2.96 | 17 / 29 |
| stomach | 44% | 74.42 | 158 / 359 | 8% | 0.43 | 24 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 1.87 | 22 / 45 |
| eye | 0% | 0 | 0 / 0 | 49% | 2.13 | 39 / 80 |
| heart | 41% | 84.35 | 354 / 861 | 0% | 0 | 0 / 0 |
| muscle | 17% | 31.02 | 139 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 14% | 19.73 | 127 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007155 | Biological process | cell adhesion |
| GO_0005615 | Cellular component | extracellular space |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0043395 | Molecular function | heparan sulfate proteoglycan binding |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | FBLN7 |
| Protein name | FBLN7 protein (Fibulin 7) Fibulin-7 (FIBL-7) Fibulin 7 |
| Synonyms | TM14 |
| Description | FUNCTION: An adhesion molecule that interacts with extracellular matrix molecules in developing teeth and may play important roles in differentiation and maintenance of odontoblasts as well as in dentin formation. . |
| Accessions | Q8IY13 H7BZ65 Q53RD9 ENST00000331203.7 [Q53RD9-1] B8ZZC1 ENST00000409450.7 [Q53RD9-2] ENST00000409903.5 ENST00000272559.4 ENST00000441565.5 ENST00000409667.7 [Q53RD9-4] |
